Molecular mechanisms of treatment resistance in glioblastoma

A Ou, WKA Yung, N Majd - International journal of molecular sciences, 2020 - mdpi.com
Glioblastoma is the most common malignant primary brain tumor in adults and is almost
invariably fatal. Despite our growing understanding of the various mechanisms underlying …

The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis

M Kuksis, Y Gao, W Tran, C Hoey, A Kiss… - Neuro …, 2021 - academic.oup.com
Background Patients with metastatic breast cancer (MBC) are living longer, but the
development of brain metastases often limits their survival. We conducted a systematic …

A review on the role of cyclin dependent kinases in cancers

S Ghafouri-Fard, T Khoshbakht, BM Hussen… - Cancer Cell …, 2022 - Springer
The Cyclin-dependent kinase (CDK) class of serine/threonine kinases has crucial roles in
the regulation of cell cycle transition and is mainly involved in the pathogenesis of cancers …

Mechanisms of cell cycle arrest and apoptosis in glioblastoma

K Gousias, T Theocharous, M Simon - Biomedicines, 2022 - mdpi.com
Cells of glioblastoma, the most frequent primary malignant brain tumor, are characterized by
their rapid growth and infiltration of adjacent healthy brain parenchyma, which reflects their …

TME-targeted approaches of brain metastases and its clinical therapeutic evidence

IM Khan, SU Khan, HSS Sala, MU Khan… - Frontiers in …, 2023 - frontiersin.org
The tumor microenvironment (TME), which includes both cellular and non-cellular elements,
is now recognized as one of the major regulators of the development of primary tumors, the …

Leptomeningeal metastases from solid tumors: recent advances in diagnosis and molecular approaches

A Pellerino, PK Brastianos, R Rudà, R Soffietti - Cancers, 2021 - mdpi.com
Simple Summary Leptomeningeal metastases are a devastating complication of solid
tumors with poor survival, regardless of the type of treatments. The limited efficacy of …

Evolving treatment strategies of brain metastases from breast cancer: current status and future direction

JS Kim, IA Kim - Therapeutic Advances in Medical Oncology, 2020 - journals.sagepub.com
Remarkable progress in breast cancer treatment has improved patient survival, resulting in
an increased incidence of brain metastasis (BM). Current treatment options for BM are …

Management of brain and leptomeningeal metastases from breast cancer

A Pellerino, V Internò, F Mo, F Franchino… - International Journal of …, 2020 - mdpi.com
The management of breast cancer (BC) has rapidly evolved in the last 20 years. The
improvement of systemic therapy allows a remarkable control of extracranial disease …

A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042)

D Van Mater, S Gururangan, O Becher… - Pediatric blood & …, 2021 - Wiley Online Library
Background Disruption of cell‐cycle regulators is a potential therapeutic target for brain
tumors in children and adolescents. The aim of this study was to determine the maximum …

Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment

T Melnyk, E Masiá, O Zagorodko… - Journal of Controlled …, 2023 - Elsevier
Brain tumors represent the second most common cause of pediatric cancer death, with
malignant gliomas accounting for∼ 75% of pediatric deaths. Palbociclib, a selective cyclin …